申请人:THERAVANCE BIOPHARMA R&D IP LLC
公开号:WO2020123453A2
公开(公告)日:2020-06-18
The present disclosure provides inhibitors of activin receptor-like kinase 5 (ALK5). Also disclosed are methods to modulate the activity of ALK5 and methods of treatment of disorders mediated by ALK5.